Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorWilder-Smith, Annelies
dc.contributor.authorWei, Yinghui
dc.contributor.authorVelho Barreto de Araújo, Thalia
dc.contributor.authorVanKerkhove, Maria
dc.contributor.authorTurchi Martelli, Celina Maria
dc.contributor.authorTurchi, Marília Dalva
dc.contributor.authorSoriano Arandes, Antoni
dc.date.accessioned2019-07-19T07:55:38Z
dc.date.available2019-07-19T07:55:38Z
dc.date.issued2019-06-18
dc.identifier.citationWilder-Smith A, Wei Y, Araújo TVB de, VanKerkhove M, Turchi Martelli CM, Turchi MD, et al. Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their inf. BMJ Open. 2019;9(6):e026092.
dc.identifier.issn2044-6055
dc.identifier.urihttp://hdl.handle.net/11351/4190
dc.descriptionMicrocephaly; Zika virus; Congenital zika syndrome
dc.description.abstractINTRODUCTION: Zika virus (ZIKV) infection during pregnancy is a known cause of microcephaly and other congenital and developmental anomalies. In the absence of a ZIKV vaccine or prophylactics, principal investigators (PIs) and international leaders in ZIKV research have formed the ZIKV Individual Participant Data (IPD) Consortium to identify, collect and synthesise IPD from longitudinal studies of pregnant women that measure ZIKV infection during pregnancy and fetal, infant or child outcomes. METHODS AND ANALYSIS: We will identify eligible studies through the ZIKV IPD Consortium membership and a systematic review and invite study PIs to participate in the IPD meta-analysis (IPD-MA). We will use the combined dataset to estimate the relative and absolute risk of congenital Zika syndrome (CZS), including microcephaly and late symptomatic congenital infections; identify and explore sources of heterogeneity in those estimates and develop and validate a risk prediction model to identify the pregnancies at the highest risk of CZS or adverse developmental outcomes. The variable accuracy of diagnostic assays and differences in exposure and outcome definitions means that included studies will have a higher level of systematic variability, a component of measurement error, than an IPD-MA of studies of an established pathogen. We will use expert testimony, existing internal and external diagnostic accuracy validation studies and laboratory external quality assessments to inform the distribution of measurement error in our models. We will apply both Bayesian and frequentist methods to directly account for these and other sources of uncertainty. ETHICS AND DISSEMINATION: The IPD-MA was deemed exempt from ethical review. We will convene a group of patient advocates to evaluate the ethical implications and utility of the risk stratification tool. Findings from these analyses will be shared via national and international conferences and through publication in open access, peer-reviewed journals. TRIAL REGISTRATION NUMBER: PROSPERO International prospective register of systematic reviews (CRD42017068915).
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.ispartofseriesBMJ Open;9(6)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectVirosis
dc.subjectCervell - Malalties
dc.subjectRessenyes sistemàtiques (Investigació mèdica)
dc.subject.meshZika Virus Infection
dc.subject.mesh/congenital
dc.subject.meshMicrocephaly
dc.subject.meshSystematic Reviews as Topic
dc.titleUnderstanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1136/bmjopen-2018-026092
dc.subject.decsinfección por el virus del Zika
dc.subject.decs/congénito
dc.subject.decsmicrocefalia
dc.subject.decsrevisiones sistemáticas como asunto
dc.relation.publishversionhttps://bmjopen.bmj.com/content/9/6/e026092
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Wilder-Smith A] Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. [Wei Y] Centre for Mathematical Sciences, University of Plymouth, Plymouth, UK. [Araújo TVB] Department of Social Medicine, Universidade Federal de Pernambuco, Recife, Brazil. [VanKerkhove M] Health Emergencies Programme, Organisation mondiale de la Sante, Geneve, Switzerland. [Turchi Martelli CM] Department of Collective Health, Institute Aggeu Magalhães (CPqAM), Oswaldo Cruz Foundation, Recife, Brazil. [Turchi MD] Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiânia, Brazil. [Soriano-Arandes A] Servei de Pediatria, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
dc.identifier.pmid31217315
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record